Delivery Order SPE2DR25D1053-SPE2DR26FT374
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,097.06 to AmerisourceBergen Drug Corp for CombiPatch 0.05-0.14 mg transdermal patches (8-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside award, meaning it was competitively awarded without restrictions to small businesses or other designated groups. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,695.21 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for CombiPatch 0.05-0.14 mg transdermal patches (eight-count units). This firm fixed-price delivery order, with a completion date of August 13, 2025, represents a small-value pharmaceutical procurement under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a $2,254.84 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging), with completion expected by September 18, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- This delivery order, valued at $1,463.46, was awarded to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count) with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a $1,295.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH TDBW 8S on October 29, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside contract represents a pediatric or specialized pharmaceutical delivery under the company's existing relationship with DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $1,050.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH 0.05-0.14 MG PTCH 8S. The order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility over the period of August 8-9, 2023. As the DLA is responsible for procuring medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order is likely to deliver transdermal combination hormone replacement patches for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count package) with a ceiling value of $1,481.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,779.42 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 MG transdermal patches (8-count) on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price, non-competitive delivery order was fulfilled without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT374Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,259.92 to AmerisourceBergen Drug Corp for CombiPatch 0.05-0.14 mg patches (8-count) on October 28, 2025, with completion targeted for October 29, 2025. This firm fixed-price, competitively awarded delivery order is issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle authorized through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products ranging from specialty medications to generic drugs, vaccines, and medical devices across multiple therapeutic domains. This CombiPatch order reflects the company's role as a primary pharmaceutical supplier within DLA's medical supply chain, enabling efficient procurement of transdermal hormone replacement therapy products for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/28/25 |